Abel Hall, LLC

SEC CIK: 0002013339
Latest filing: Jul 24, 2026

SEC filings (opens in a new tab)

HRTX holding history

Heron Therapeutics, Inc. in every 13F filed by Abel Hall, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HRTX overview All 13F holders of HRTX Full Q2 2026 holdings

Shares (Q2 2026): 213,185
Value: $91.0K
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2025

Holdings of HRTX by Abel Hall, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	213,185	$91.0K	<0.1%	+196,278+1,160.9%	Added	Holders
Q1 2026	16,907	$13.5K	<0.1%	−29,269−63.4%	Reduced	Holders
Q4 2025	46,176	$60.0K	<0.1%	+46,176	New	Holders